Where was the HIFU for localised prostate cancer ?
David P Smith et al (1), report that radical prostatectomy for
localised prostate cancer leads to significant urinary and sexual
dysfunctions. However, it is surprising that patients diagnosed with
prostate cancer between 2000 and 2002 do not have the choice to be treated
by High Intensity Focused Ultrasound (HIFU). Indeed, HIFU is a minimally
invasive treatment and effective long-term cancer control for localised
prostate cancer stages I and II (2). Moreover, contrary to radical
prostatectomy HIFU has little side effects on urinary and sexual functions
(3, 4).
References
1. Smith DP, King MT, Egger S, Berry MP, Stricker PD, Cozzi P, Ward
J, O'Connell DL, Armstrong BK. Quality of life three years after
diagnosis of localised prostate cancer: population based cohort study.
BMJ. 2009;339:b4817.
2. Blana A, Murat FJ, Walter B, Thuroff S, Wieland WF, Chaussy C,
Gelet A. First analysis of the long-term results with transrectal HIFU in
patients with localised prostate cancer. Eur Urol. 2008;53:1194-201.
3. Poissonnier L, Chapelon JY, Rouvière O, Curiel L, Bouvier R,
Martin X, Dubernard JM, Gelet A. Control of prostate cancer by transrectal
HIFU in 227 patients. Eur Urol. 2007;51:381-7.
4. Maestroni U, Ziveri M, Azzolini N, Dinale F, Ziglioli F,
Campaniello G, Frattini A, Ferretti S.High Intensity Focused Ultrasound
(HIFU): a useful alternative choice in prostate cancer treatment.
Preliminary results. Acta Biomed. 2008;79:211-6.
Competing interests:
None declared
Competing interests:
No competing interests
23 January 2010
Souhail Alouini
Surgeon
Centre Hospitalier Régional d'Orléans, 45000, Orléans, France
Rapid Response:
Where was the HIFU for localised prostate cancer ?
David P Smith et al (1), report that radical prostatectomy for
localised prostate cancer leads to significant urinary and sexual
dysfunctions. However, it is surprising that patients diagnosed with
prostate cancer between 2000 and 2002 do not have the choice to be treated
by High Intensity Focused Ultrasound (HIFU). Indeed, HIFU is a minimally
invasive treatment and effective long-term cancer control for localised
prostate cancer stages I and II (2). Moreover, contrary to radical
prostatectomy HIFU has little side effects on urinary and sexual functions
(3, 4).
References
1. Smith DP, King MT, Egger S, Berry MP, Stricker PD, Cozzi P, Ward
J, O'Connell DL, Armstrong BK. Quality of life three years after
diagnosis of localised prostate cancer: population based cohort study.
BMJ. 2009;339:b4817.
2. Blana A, Murat FJ, Walter B, Thuroff S, Wieland WF, Chaussy C,
Gelet A. First analysis of the long-term results with transrectal HIFU in
patients with localised prostate cancer. Eur Urol. 2008;53:1194-201.
3. Poissonnier L, Chapelon JY, Rouvière O, Curiel L, Bouvier R,
Martin X, Dubernard JM, Gelet A. Control of prostate cancer by transrectal
HIFU in 227 patients. Eur Urol. 2007;51:381-7.
4. Maestroni U, Ziveri M, Azzolini N, Dinale F, Ziglioli F,
Campaniello G, Frattini A, Ferretti S.High Intensity Focused Ultrasound
(HIFU): a useful alternative choice in prostate cancer treatment.
Preliminary results. Acta Biomed. 2008;79:211-6.
Competing interests:
None declared
Competing interests: No competing interests